​
​

Guardion Health Sciences (GHSI) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Guardion Health Sciences Revenue Highlights

Latest Revenue (Y)

$12.25M

Latest Revenue (Q)

$36.35K

Main Segment (Y)

Vision Testing Diagnotics

Main Geography (Y)

Vision Testing Diagnotics

Guardion Health Sciences Revenue by Period

Guardion Health Sciences Revenue by Year

DateRevenueChange
2023-12-31$12.25M10.85%
2022-12-31$11.05M52.77%
2021-12-31$7.23M282.74%
2020-12-31$1.89M109.30%
2019-12-31$902.94K-4.16%
2018-12-31$942.15K115.42%
2017-12-31$437.35K210.11%
2016-12-31$141.03K25.01%
2015-12-31$112.81K-

Guardion Health Sciences generated $12.25M in revenue during NA 2023, up 10.85% compared to the previous quarter, and up 1300.06% compared to the same period a year ago.

Guardion Health Sciences Revenue by Quarter

DateRevenueChange
2024-06-30$36.35K-98.79%
2024-03-31$3.00M2.17%
2023-12-31$2.94M-12.03%
2023-09-30$3.34M19.62%
2023-06-30$2.79M-12.43%
2023-03-31$3.19M16.85%
2022-12-31$2.73M2.36%
2022-09-30$2.66M-18.68%
2022-06-30$3.28M37.35%
2022-03-31$2.38M-9.24%
2021-12-31$2.63M-16.55%
2021-09-30$3.15M157.30%
2021-06-30$1.22M424.53%
2021-03-31$233.30K16.63%
2020-12-31$200.02K-21.00%
2020-09-30$253.19K-78.74%
2020-06-30$1.19M384.66%
2020-03-31$245.72K3.13%
2019-12-31$238.27K47.84%
2019-09-30$161.16K-38.25%
2019-06-30$260.97K7.60%
2019-03-31$242.54K3.60%
2018-12-31$234.11K-20.43%
2018-09-30$294.23K33.27%
2018-06-30$220.78K14.37%
2018-03-31$193.04K-25.39%
2017-12-31$258.74K312.68%
2017-09-30$62.70K4.54%
2017-06-30$59.98K7.21%
2017-03-31$55.94K14.55%
2016-12-31$48.83K45.01%
2016-09-30$33.68K14.61%
2016-06-30$29.38K0.86%
2016-03-31$29.13K-

Guardion Health Sciences generated $36.35K in revenue during Q2 2024, up -98.79% compared to the previous quarter, and up 1.14% compared to the same period a year ago.

Guardion Health Sciences Revenue Breakdown

Guardion Health Sciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 18
Vision Testing Diagnotics$609.36K
Corporate Segment-
Medical Foods$332.80K

Guardion Health Sciences's latest annual revenue breakdown by segment (product or service), as of Dec 18: Vision Testing Diagnotics (64.68%), and Medical Foods (35.32%).

Quarterly Revenue by Product

Product/ServiceMar 24Sep 21Mar 20Mar 19Sep 18Jun 18Mar 18
Nutritional Supplements-------
Diagnostics Equipment-$39.09K-----
Clinical Nutrition-$3.11M-----
Other--$14.74K----
Vision Testing Diagnostics---$142.60K---
Medical Foods---$99.93K---
VectorVision medical devices and supplies----$208.15K$140.78K$120.90K
Lumega-Z and supplements----$86.08K$79.99K$72.14K

Guardion Health Sciences Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 18
Corporate Segment-
Vision Testing Diagnotics$609.36K
Medical Foods$332.80K

Guardion Health Sciences's latest annual revenue breakdown by geography, as of Dec 18: Vision Testing Diagnotics (64.68%), and Medical Foods (35.32%).

Quarterly Revenue by Country

CountrySep 21Mar 20Mar 19Sep 18Jun 18Mar 18
Clinical Nutrition$3.11M-----
Diagnostics Equipment$39.09K-----
Other-$14.74K----
Vision Testing Diagnostics--$142.60K---
Medical Foods--$99.93K---
VectorVision medical devices and supplies---$208.15K$140.78K$120.90K
Lumega-Z and supplements---$86.08K$79.99K$72.14K

Guardion Health Sciences's latest quarterly revenue breakdown by geography, as of Sep 21: Clinical Nutrition (98.76%), and Diagnostics Equipment (1.24%).

Guardion Health Sciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PTPIPetros Pharmaceuticals$5.82B$1.42M
ORGOOrganogenesis$433.14M$115.18M
LFCRLifecore Biomedical$128.26M$24.70M
AQSTAquestive Therapeutics$50.58M$13.54M
IMCCIM Cannabis$48.80M$12.06M
QLIQilian Group$46.47M$17.31M
TKNOAlpha Teknova$36.68M$9.58M
BFRIBiofrontera$34.01M$7.83M
UPCUniverse Pharmaceuticals$32.31M$13.84M
AGRXAgile Therapeutics$19.59M$5.58M
GHSIGuardion Health Sciences$12.25M$36.35K
EVOKEvoke Pharma$5.18M$2.65M
ADMPAdamis Pharmaceuticals$4.76M$9.06M
AKANAkanda$2.16M$762.61K
CYTHCyclo Therapeutics$1.08M$123.10K
ACRXTalphera$651.00K$117.00K
SHPHShuttle Pharmaceuticals--

GHSI Revenue FAQ

What is Guardion Health Sciences’s yearly revenue?

Guardion Health Sciences's yearly revenue for 2023 was $12.25M, representing an increase of 10.85% compared to 2022. The company's yearly revenue for 2022 was $11.05M, representing an increase of 52.77% compared to 2021. GHSI's yearly revenue for 2021 was $7.23M, representing an increase of 282.74% compared to 2020.

What is Guardion Health Sciences’s quarterly revenue?

Guardion Health Sciences's quarterly revenue for Q2 2024 was $36.35K, a -98.79% decrease from the previous quarter (Q1 2024), and a -98.70% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $3M, a 2.17% increase from the previous quarter (Q4 2023), and a -5.84% decrease year-over-year (Q1 2023). GHSI's quarterly revenue for Q4 2023 was $2.94M, a -12.03% decrease from the previous quarter (Q3 2023), and a 7.68% increase year-over-year (Q4 2022).

What is Guardion Health Sciences’s revenue growth rate?

Guardion Health Sciences's revenue growth rate for the last 3 years (2021-2023) was 69.34%, and for the last 5 years (2019-2023) was 1256.52%.

What are Guardion Health Sciences’s revenue streams?

Guardion Health Sciences's revenue streams in c 18 are Vision Testing Diagnotics, and Medical Foods. Vision Testing Diagnotics generated $609.36K in revenue, accounting 64.68% of the company's total revenue Medical Foods generated $332.8K in revenue, accounting 35.32% of the company's total revenue

What is Guardion Health Sciences’s main source of revenue?

For the fiscal year ending Dec 18, the largest source of revenue of Guardion Health Sciences was Vision Testing Diagnotics. This segment made a revenue of $609.36K, representing 64.68% of the company's total revenue.